ARCHIVES

In Brief: OMB Misses Deadline On 1989 Budget, Blames Late Actin On ’88 Money Bill; Raney Heads AACE

This article is from The Cancer Letter archive.

Vol. 14 No. 02 | January 8, 1988

Download PDF Visit The Full Archive

Related Articles

FDA says new tools needed to speed therapeutics development.

March 26, 2004

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Committee Unblinds Phase III Zytiga Study

March 30, 2012

AACI Remains Split On Guidelines; Terry Proposes 25 Percent Limit On Staff Investigator Salaries

January 30, 1981

In Brief: Congressmen Press Or More Exploratory Grant Money: Murphy Reelected By UICC

August 6, 1976

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989